NMC Health PLC (LON:NMC) Rating Reaffirmed
In a recent report sent to clients and investors on 27 November, The Buy rating of NMC Health PLC (LON:NMC) shares was reaffirmed at Investec, who now has a GBX 1025.00 Estimated Target Price on the stock. Investec’s Estimated Target Price may suggest a possible upside of 18.09% from the last close price of the company.
From a total of 2 analysts covering NMC Health PLC (LON:NMC) stock, 2 rate it a ”Buy”, 0 a “Sell”, and 0 a ”Hold”. This means that 100% of the ratings are positive. The highest target price is GBX 1120 while the lowest target price is GBX 900. The mean of all analyst targets is GBX 1072.50 with a 21.88% above today’s (GBX 880) stock price. NMC Health PLC was the topic of 5 analyst reports since August 26, 2015 according to the firm StockzIntelligence Inc. Investec maintained shares on November 27 with “Buy” rating.
The stock decreased 1.35% or GBX 12 on November 27, striking GBX 880. Approximately 41,762 shares of stock traded hands. NMC Health PLC (LON:NMC) has risen 14.73% since May 1, 2015 and is uptrending. It has outperformed by 15.62% the S&P500.
NMC Health plc is a healthcare operator in the United Arab Emirates. The company has a market cap of 1.64 billion GBP. The Company, through its subsidiaries, is engaged in providing professional medical services, wholesale of pharmaceutical goods, medical equipment, cosmetics, food and IT services and products in the United Arab Emirates. It has 32.57 P/E ratio. It operates through two divisions: healthcare segment and distribution and services segment.